BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2020 1:53:48 PM | Browse: 873 | Download: 2527
 |
Received |
|
2020-03-18 02:26 |
|
Peer-Review Started |
|
2020-03-18 02:29 |
|
First Decision by Editorial Office Director |
|
2020-05-28 21:17 |
|
Return for Revision |
|
2020-05-28 21:17 |
|
Revised |
|
2020-07-06 05:04 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-09-08 10:57 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-09-08 20:36 |
|
Articles in Press |
|
2020-09-08 20:36 |
|
Edit the Manuscript by Language Editor |
|
2020-09-23 22:59 |
|
Typeset the Manuscript |
|
2020-10-13 00:34 |
|
Publish the Manuscript Online |
|
2020-10-14 13:53 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shu-Guang Zhu, Hai-Bo Li, Ze-Nan Yuan, Wei Liu, Qing Yang, Ying Cheng, Wen-Jing Wang, Guo-Ying Wang and Hua Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National 13th Five-Year Science and Technology Plan Major Projects of China |
2017ZX10203205-006-001 |
| Sci-tech Research Development Program of Guangzhou City |
201607010024 |
| Science and Technology Planning Project of Guangdong Province |
2017B020209004 |
|
| Corresponding Author |
Guo-Ying Wang, MD, PhD, Doctor, Doctor, Surgeon, Department of Hepatic Surgery and Liver Transplantation, The Third Affiliated Hospital of Sun Yat-Sen University, No. 600 Tianhe Road, Tianhe District, Guangzhou 510000, Guangdong Province, China. wanggy3@126.com |
| Key Words |
Sarcomatoid hepatocellular carcinoma; Hepatocellular carcinoma; Programmed death-ligand 1; Immunotherapy; Nivolumab; Case report |
| Core Tip |
Here, we report a rare case of advanced sarcomatoid hepatocellular carcinoma (SHC), which was successfully treated with the anti-programmed cell death 1 antibody. To the best of our knowledge, this is the first case report on the successful treatment of advanced SHC using immunotherapy. |
| Publish Date |
2020-10-14 13:53 |
| Citation |
Zhu SG, Li HB, Yuan ZN, Liu W, Yang Q, Cheng Y, Wang WJ, Wang GY, Li H. Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report. World J Gastrointest Oncol 2020; 12(10): 1209-1215 |
| URL |
https://www.wjgnet.com/1948-5204/full/v12/i10/1209.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v12.i10.1209 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
